168 related articles for article (PubMed ID: 4121926)
1. Formation of C3a and C5a anaphylatoxins in whole human serum after inhibition of the anaphylatoxin inactivator.
Vallota EH; Müller-Eberhard HJ
J Exp Med; 1973 May; 137(5):1109-23. PubMed ID: 4121926
[TBL] [Abstract][Full Text] [Related]
2. Purification and partial characterization of human and porcine C3a anaphylatoxin.
Hugli TE; Vallota EH; Müller-Eberhard HJ
J Biol Chem; 1975 Feb; 250(4):1472-8. PubMed ID: 803505
[TBL] [Abstract][Full Text] [Related]
3. Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum.
Bokisch VA; Müller-Eberhard HJ; Cochrane CG
J Exp Med; 1969 May; 129(5):1109-30. PubMed ID: 5778786
[TBL] [Abstract][Full Text] [Related]
4. Effect of C3a and C5a anaphylatoxins on guinea-pig isolated blood vessels.
Marceau F; Hugli TE
J Pharmacol Exp Ther; 1984 Sep; 230(3):749-54. PubMed ID: 6332191
[TBL] [Abstract][Full Text] [Related]
5. C4a: the third anaphylatoxin of the human complement system.
Gorski JP; Hugli TE; Müller-Eberhard HJ
Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5299-302. PubMed ID: 291947
[TBL] [Abstract][Full Text] [Related]
6. Activation of the third complement component (C3) and C3a generation in cardiac anaphylaxis: histamine release and associated inotropic and chronotropic effects.
del Balzo U; Polley MJ; Levi R
J Pharmacol Exp Ther; 1988 Sep; 246(3):911-6. PubMed ID: 2458450
[TBL] [Abstract][Full Text] [Related]
7. Anaphylatoxin release from the third component of human complement by hydroxylamine.
Budzko DB; Müller-Eberhard H
Science; 1969 Aug; 165(3892):506-7. PubMed ID: 5815704
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary injury induced by C3a and C5a anaphylatoxins.
Stimler NP; Hugli TE; Bloor CM
Am J Pathol; 1980 Aug; 100(2):327-48. PubMed ID: 6967702
[TBL] [Abstract][Full Text] [Related]
9. Complement as a mediator of inflammation. 3. Purification of the activity with anaphylatoxin properties generated by interaction of the first four components of complement and its identification as a cleavage product of C'3.
da Silva WD; Eisele JW; Lepow IH
J Exp Med; 1967 Dec; 126(6):1027-48. PubMed ID: 6069927
[TBL] [Abstract][Full Text] [Related]
10. Identification of classical anaphylatoxin as the des-Arg form of the C5a molecule: evidence of a modulator role for the oligosaccharide unit in human des-Arg74-C5a.
Gerard C; Hugli TE
Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1833-7. PubMed ID: 6940191
[TBL] [Abstract][Full Text] [Related]
11. Interaction of human anaphylatoxin C3a with rat mast cells demonstrated by immunofluorescence.
ter Laan B; Molenaar JL; Feltkamp-Vroom TM; Pondman KW
Eur J Immunol; 1974 May; 4(5):393-5. PubMed ID: 4136830
[No Abstract] [Full Text] [Related]
12. The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement.
Cochrane CG; Müller-Eberhard HJ
J Exp Med; 1968 Feb; 127(2):371-86. PubMed ID: 4383923
[TBL] [Abstract][Full Text] [Related]
13. Anaphylatoxin inactivator of human plasma: its isolation and characterization as a carboxypeptidase.
Bokisch VA; Müller-Eberhard HJ
J Clin Invest; 1970 Dec; 49(12):2427-36. PubMed ID: 4098172
[TBL] [Abstract][Full Text] [Related]
14. Structural elements of anaphylatoxin obtained by contact activation of hog serum.
Liefländer M; Dielenberg D; Schmidt G; Vogi W
Hoppe Seylers Z Physiol Chem; 1972 Mar; 353(3):385-92. PubMed ID: 5028204
[No Abstract] [Full Text] [Related]
15. Release of histamine from rat mast cells by the complement peptides C3a and C5a.
Johnson AR; Hugli TE; Müller-Eberhard HJ
Immunology; 1975 Jun; 28(6):1067-80. PubMed ID: 48505
[TBL] [Abstract][Full Text] [Related]
16. A recombinant hybrid anaphylatoxin with dual C3a/C5a activity.
Bautsch W; Kretzschmar T; Stühmer T; Kola A; Emde M; Köhl J; Klos A; Bitter-Suermann D
Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):261-6. PubMed ID: 1445269
[TBL] [Abstract][Full Text] [Related]
17. Chemistry and biology of the anaphylatoxin related serum peptide system. I. Purification, crystallization and properties of classical anaphylatoxin from rat serum.
Wissler JH
Eur J Immunol; 1972 Feb; 2(1):73-83. PubMed ID: 5082613
[No Abstract] [Full Text] [Related]
18. Anaphylatoxin in its relation to the complement system.
Jensen J
Science; 1967 Mar; 155(3766):1122-3. PubMed ID: 6021911
[TBL] [Abstract][Full Text] [Related]
19. Ability of the T cell-replacing polyanion dextran sulfate to trigger the alternate pathway of complement activation.
Hadding U; Dierich M; König W; Limbert M; Schorlemmer HU; Bitter-Suermann D
Eur J Immunol; 1973 Aug; 3(8):527-9. PubMed ID: 4127819
[No Abstract] [Full Text] [Related]
20. A serum factor in chronic hypocomplementemic hephritis distinct from immunoglobulins and activating the alternate pathway of complement.
Vallota EH; Götze O; Spiegelberg HL; Forristal J; West CD; Müller-Eberhard HJ
J Exp Med; 1974 May; 139(5):1249-61. PubMed ID: 4207623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
